Marrone Bio Innovations News

News

0

Ticker

MBII

ISIN

US57165B1061

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

Marrone Bio Innovations Eulerpool News

9/22/2025, 10:53:31 PM

Fusionsfieber in der Immobilienbranche: Compass und Anywhere Real Estate schließen Milliardenfusion ab

Merger Fever in the Real Estate Industry: Compass and Anywhere Real Estate Complete Billion-Dollar Merger

Marrone Bio Innovations Stock News

Marrone Bio Innovations is being monitored by journalists and investors worldwide. We gather the latest Marrone Bio Innovations news here.

March 8·
CNBC
Leadership or loneliness? Making sense of why executives are eager to get employees back in the office
March 4·
CNBC
Disney+ to launch cheaper ad-supported tier later this year
March 3·
CNBC
From Michael Keaton to Ben Affleck, Batman's legacy at the box office means big bucks
February 28·
CNBC
Disney, Warner Bros, other Hollywood studios pause theatrical releases in Russia
February 23·
Yahoo
Koppers (KOP) Q4 Earnings Beat Estimates
February 22·
Yahoo
Marrone Bio Announces CFO Transition
February 9·
CNBC
Serena Williams to star in Tonal's Super Bowl ad. Home gym tells women to 'own your strength'
January 27·
CNBC
5 things to know before the stock market opens Thursday
January 27·
CNBC
Stocks making the biggest moves premarket: McDonald's, Blackstone, Netflix and others
January 23·
CNBC
Earnings playbook: A complete guide to this week's reports, including the first of tech
January 18·
CNBC
Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
January 14·
Benzinga
48 Biggest Movers From Yesterday
January 13·
CNBC
Supreme Court vaccine mandate ruling won't bar companies from demanding Covid shots for workers — Biden vows to advocate for that
January 6·
Thefly.com
Marrone Bio relocates corporate headquarters to North Carolina
January 3·
Nasdaq
Is Marrone Bio Innovations (NASDAQ:MBII) A Risky Investment?
December 28·
Thefly.com
Lake Street names 18 small cap best ideas for 2022
December 26·
CNBC
With just $36.6 million in ticket sales, ‘West Side Story’ is officially a box office bomb
December 20·
Yahoo
What Type Of Shareholders Own The Most Number of Marrone Bio Innovations, Inc. (NASDAQ:MBII) Shares?
November 24·
Yahoo
7 Hot Penny Stocks to Buy for December That Are Positioned to Pop
November 10·
Yahoo
Marrone Bio Innovations, Inc. (MBII) Reports Q3 Loss, Misses Revenue Estimates

Marrone Bio Innovations Stock Press Releases

Marrone Bio Innovations regularly publishes news on the company's website that are relevant for investors.

July 11•
Marrone Bio Innovations
Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp.
May 11•
Marrone Bio Innovations
Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Results
April 27•
Marrone Bio Innovations
Marrone Bio Innovations to Report First Quarter 2022 Results on Wednesday, May 11 at 4:30 p.m. Eastern Time
March 28•
Marrone Bio Innovations
Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2021 Financial Results
March 23•
Marrone Bio Innovations
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates NEOG, ADOC, MBII, SKIL
March 16•
Marrone Bio Innovations
Bioceres Crop Solutions and Marrone Bio Announce Merger Agreement
March 8•
Marrone Bio Innovations
Marrone Bio Innovations to Report Fourth Quarter and Full Year 2021 Results on Monday, March 28 at 4:30 p.m. Eastern Time
February 22•
Marrone Bio Innovations
Marrone Bio Announces CFO Transition
January 18•
Marrone Bio Innovations
Marrone Bio Innovations Issues Shareholder Letter
January 6•
Marrone Bio Innovations
Marrone Bio’s Inventory Line of Credit Increased to Support Sales and Manufacturing Growth
January 6•
Marrone Bio Innovations
Marrone Bio Relocates Corporate Headquarters to Raleigh, North Carolina
December 16•
Marrone Bio Innovations
Marrone Bio Warrant Holders Exercise Final Tranche, Eliminating Warrant Overhang
December 16•
Marrone Bio Innovations
Marrone Bio Optimizes Bioherbicide with New Bacteria Strains, Accelerates Product Development to Enter $27 Billion Herbicide Market¹
December 8•
Marrone Bio Innovations
Marrone Bio’s Next-Generation Product for Environmentally Sustainable Pest Control Demonstrates Substantial Yield Gains in 2021 Field Trials
November 17•
Marrone Bio Innovations
Marrone Bio Achieves Excellent Climate Impact Score for Venerate® XC Bioinsecticide
November 10•
Marrone Bio Innovations
Marrone Bio Innovations, Inc. Reports Third-Quarter 2021 Financial Results
November 8•
Marrone Bio Innovations
Marrone Bio Innovations Receives Nasdaq Notice Regarding Failure to Satisfy a Continued Listing Rule
November 1•
Marrone Bio Innovations
Marrone Bio Submits Regulatory Packages for Nematicides/Insecticides in United States and Brazil
October 27•
Marrone Bio Innovations
Marrone Bio Innovations to Report Third Quarter 2021 Results on Wednesday, November 10 at 4:30 p.m. Eastern Time
September 28•
Marrone Bio Innovations
Marrone Bio Advances Novel Herbicides
September 9•
Marrone Bio Innovations
Marrone Bio Prepares to Submit Registration for Next-Generation Crop Protection Product in North America
August 16•
Marrone Bio Innovations
Marrone Bio Innovations, Inc. Reports Second-Quarter 2021 Financial Results
August 16•
Marrone Bio Innovations
Marrone Bio Innovations Collaborates with Terramera to Enhance Product Performance and Expedite Novel Product Development
August 2•
Marrone Bio Innovations
Marrone Bio Innovations to Report Second Quarter 2021 Results on Monday, August 16 at 4:30 p.m. Eastern Time
June 10•
Marrone Bio Innovations
180 Life Sciences Corp. Announces the Appointment of Pamela Marrone, PhD and Frank Knuettel II, MBA to Board of Directors
June 3•
Marrone Bio Innovations
Marrone Bio Innovations Partners with ATP Nutrition to Distribute Stargus® Biofungicide in Canada
May 13•
Marrone Bio Innovations
Marrone Bio Innovations Issues Shareholder Letter
May 13•
Marrone Bio Innovations
Marrone Bio Innovations, Inc. Reports First-Quarter 2021 Financial Results
May 6•
Marrone Bio Innovations
BIOSt® Nematicide Seed Treatment Reduces Greenhouse Gas Emissions in Soybeans and Corn by 85%+ Compared to Conventional Pesticides
April 29•
Marrone Bio Innovations
Marrone Bio Innovations to Report First Quarter 2021 Results on Thursday, May 13th at 4:30 p.m. Eastern Time

Marrone Bio Innovations News 2026

This page contains all current news, analysis and press releases for Marrone Bio Innovations stock (MBII, ISIN: US57165B1061). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at Marrone Bio Innovations.

Marrone Bio Innovations Stock

Marrone Bio Innovations Marrone Bio Innovations Inc is an American company that has been operating in the field of biological pest control since 2006. It was founded by chemist Dr. Pamela Marrone and is headquartered in Davis, California. The company's business model is based on developing safe and effective biological pest control products made from natural ingredients. The aim is to minimize the environmental impact of agriculture. The company is divided into different divisions, including biological plant protection, biological nitrogen fixation, biological weed control, and other products. Some of the well-known products include Regalia®, Venerate®, and Majestene®. Marrone Bio Innovations has gained significance in recent years and is now one of the leading companies in the field of biological pest control. The company works closely with farmers, research institutions, and regulatory authorities to develop and introduce new products, always prioritizing safety and environmental compatibility.